Antipsychotics in the Treatment of Autism

Gottfried, Carmem; Riesgo, Rudimar dos Santos

doi:10.5772/18608

Cited by 5 publications

(10 citation statements)

References 87 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In our experience, children with low intensity ASD treats, when early-treated can eventually get out from de ASD diagnosis when accessed by CARS, a rating scale of autism symptoms (Gottfried & Riesgo, 2011).…”

Section: Non-medical Treatment Of Asd Patientsmentioning

confidence: 94%

See 1 more Smart Citation

Clinical Approach in Autism: Management and Treatment

Riesgo¹,

Gottfried²,

Becker³

2013

Recent Advances in Autism Spectrum Disorders - Volume I

Self Cite

View full text Add to dashboard Cite

By definition, in autism the social deficits are characterized by lack of interest in spontaneously sharing feelings, different levels of communication deficits, difficulties in imaginative plays, restrictive repertoire of interests, non-functional routine fixations, as well as stereotypies and other motor alterations, such as flapping with hands, circular movements and others (Nikolov, Jonker, and Scahill 2006; Gadia, Tuchman, and Rotta 2004). While the criteria of the DSM-V (Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition) are not yet published, we still have to use the "older version". According with the DSM-IV criteria, there are five clinical situations that could be encompassed by the term "PDD" (Pervasive Developmental Disorders) or "ASD" (Autism Spectrum Disorders) with the same meaning of PDD or autism (Association 2002). Although it will change in the near future, the five current clinical ASD diagnosis admitted by DSM-IV-TR (Gadia et al., 2004) are: a) Autistic Disorder; b) Asperger Disorder (AD); c) Rett Disorder; d) Childhood Disintegrative Disorder; e) PDD-NOS (Pervasive Developmental Disorder-Not Otherwise Specified).

show abstract

Section: Non-medical Treatment Of Asd Patientsmentioning

confidence: 94%

“…In clinical practice, mood instability is more difficult to control in ASD patients compared with typically developed children (Gottfried & Riesgo, 2011). Different drugs have been used, including antipsychotics, SSRI, and lithium.…”

Section: Mood Instabilitymentioning

confidence: 99%

Clinical Approach in Autism: Management and Treatment

Riesgo¹,

Gottfried²,

Becker³

2013

Recent Advances in Autism Spectrum Disorders - Volume I

Self Cite

View full text Add to dashboard Cite

show abstract

“…These neurobehavioral syndromes can be addressed, for example, both from the clinical and from the experimental field. To our knowledge, at least in the academic environment, the best approach could be the translational type because it made us able to rapidly build a bridge between the experimental and the clinical field (Gottfried and Riesgo 2011).…”

Section: Discussionmentioning

confidence: 99%

“…In our experience, the dyad depression/anxiety is more frequent in intelligencepreserved ASD patients, such as those with Asperger disorder. Additionally, anxiety seems to increase in stress situations and also during lifetime (Gottfried and Riesgo 2011). Because of their ability to identify their own difficulties (Cederlund, Hagberg, and Gillberg 2010), patients with Asperger are more prone to became depressed.…”

Section: How Asd-associated Symptoms Change With Timementioning

confidence: 99%

Recent advances in autism spectrum disorders

Spence¹,

Tasker

Pomeroy³

2011

Current Opinion in Pediatrics

View full text Add to dashboard Cite

show abstract

“…Hasta el momento no se ha identificado un marcador biológico totalmente confiable 3 . Sin embargo, y con base en los diversos síntomas indicativos de los TEA, diferentes especialistas han sugerido una estrategia comprensible, estructurada y sistemática, tanto para el diagnóstico como para el tratamiento, con el fin de identificar las diversas capacidades y limitantes específicas en cada paciente con TEA 4 .…”

Section: Diagnósticounclassified

Aspectos genéticos y neuroendocrinos en el trastorno del espectro autista

Oviedo¹,

Manuel‐Apolinar²,

Chesnaye³

et al. 2015

Boletín Médico del Hospital Infantil de México

View full text Add to dashboard Cite

The autism spectrum disorder (ASD) was described in 1943 and is defined as a developmental disorder that affects social interaction and communication. It is usually identified in early stages of development from 18 months of age. Currently, autism is considered a neurological disorder with a spectrum covering cases of different degrees, which is associated with genetic factors, not genetic and environmental. Among the genetic factors, various syndromes have been described that are associated with this disorder. Also, the neurobiology of autism has been studied at the genetic, neurophysiological, neurochemical and neuropathological levels. Neuroimaging techniques have shown multiple structural abnormalities in these patients. There have also been changes in the serotonergic, GABAergic, catecholaminergic and cholinergic systems related to this disorder. This paper presents an update of the information presented in the genetic and neuroendocrine aspects of autism spectrum disorder.

show abstract

Antipsychotics in the Treatment of Autism

Cited by 5 publications

References 87 publications

Clinical Approach in Autism: Management and Treatment

Clinical Approach in Autism: Management and Treatment

Recent advances in autism spectrum disorders

Aspectos genéticos y neuroendocrinos en el trastorno del espectro autista

Contact Info

Product

Resources

About